Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.

Saved in:

Bibliographic Details
Title:	Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.
Authors:	Choi, John¹, Medikonda, Ravi¹, Saleh, Laura¹, Kim, Timothy¹, Pant, Ayush¹, Srivastava, Siddhartha¹, Young-Hoon Kim², Jackson, Christina¹, Luqing Tong¹, Routkevitch, Denis¹, Jackson, Christopher¹, Mathios, Dimitrios¹, Zhao, Tianna¹, Hyerim Cho³, Brem, Henry¹, Lim, Michael¹ mklim@stanford.edu
Source:	OncoImmunology. 2021, Vol. 10 Issue 1, p1-9. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	21624011
DOI:	10.1080/2162402X.2021.1956142